| Mantzourani, Efi  ORCID: https://orcid.org/0000-0002-6313-1409, Ahmed, Haroon  ORCID: https://orcid.org/0000-0002-0634-8548, Bethel, Jackie, Turner, Samantha, Akbari, Ashley, Evans, Andrew, Prettyjohns, Matthew, John, Gareth, Gunnarsson, Ronny and Cannings-John, Rebecca  ORCID: https://orcid.org/0000-0001-5235-6517
      2025.
      
      Clinical outcomes following acute sore throat assessment at community pharmacy versus general practice: a retrospective, longitudinal, data linkage study.
      Journal of Antimicrobial Chemotherapy
      80
      
        (1)
      
      , pp. 227-237.
      
      10.1093/jac/dkae400   | 
| Preview | PDF
 - Published Version Available under License Creative Commons Attribution Non-commercial. Download (790kB) | Preview | 
Abstract
Background To date, no research has compared longer-term outcomes (antibiotic provision; re-consultations; hospital admissions for quinsy; cost-effectiveness) following presentation with acute sore throat at general practice (GP) versus newer, pharmacy-led services. Methods A retrospective, longitudinal cohort study of sore throat consultations between 1 November 2018 and 28 February 2020 either with the Wales pharmacy-led sore throat test and treat (STTT) service or with a healthcare professional at GP. Individual-level pharmacy consultation data from the national Choose Pharmacy IT application were securely uploaded to the Secure Anonymised Information Linkage Databank and linked to routinely collected, anonymized, population-scale, individual-level, anonymized health and administrative data. Results Of 72 736 index consultations, 6495 (8.9%) were with STTT and 66 241 (91.1%) with GP. Antibiotic provision at the index consultation was 1382 (21%) with STTT and 25 506 (39%) with GP [adjusted odds ratio (AOR), 0.30; 95% CI, 0.27 to 0.32]. Antibiotic provision within 28 days of index occurred in 1820 (28%) STTT and 26 369 (40%) GP consultations (AOR, 0.44; 95% CI, 0.41 to 0.47). GP re-consultation rate within 28 days of index date was 21% (n = 1389) with STTT compared with 7.4% (n = 4916) with GP (AOR, 3.8; 95% CI, 3.5 to 4.1). Coding limitations may lead to overestimates of GP re-consultations rates in the STTT group. Hospital admissions for quinsy were rare in both STTT (n = 20, 0.31%) and GP (n = 274, 0.41%) (AOR, 0.68; 95% CI, 0.43 to 1.1). STTT was less costly than consultation with GP. Conclusions The pharmacy-led STTT service is safe, cost-effective, and contributes to antimicrobial stewardship.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Medicine Schools > Pharmacy | 
| Publisher: | Oxford University Press | 
| ISSN: | 0305-7453 | 
| Date of First Compliant Deposit: | 18 November 2024 | 
| Date of Acceptance: | 21 October 2024 | 
| Last Modified: | 21 Jan 2025 13:13 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/174063 | 
Actions (repository staff only)
|  | Edit Item | 

 
							

 Dimensions
 Dimensions Dimensions
 Dimensions